…sociation between disease activity and fatigue in patients with SLE. CS therapy was associated with greater fatigue, regardless of …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 326 of 2459…ly meaningful thresholds for entry and improvement, to classify haemolytic anaemia treatment response in a novel multi-domain outcome measure for …
…Objectives Introduction: Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (…
… rate (IR) of interstitial lung disease (ILD) among adults with systemic lupus erythematosus (SLE). The secondary objective was to explore possible differen…
…ients with various connective tissue diseases (CTDs), including Systemic Lupus Erythematosus (SLE), dermatomyositis (DM) or Systemic Sclerosis (SSc). Adult …
…Objectives To model SLE clinical manifestations using pathway-level patterns derived fr…
…5.2%), Black Caribbean (15.2%), Chinese (1.7%) or Other (3.3%). Lupus nephritis class was recorded. The mean number of months from diagnosis to…
…. Rituximab showed the highest response rate (86%), followed by mycophenolate mofetil (76.9%) and hydroxychloroquine (75%) ( table 1).Abstract PO:10:…
…without any recurrence of the testicular vasculitis.Conclusions Lupus orchitis is a rare manifestation of systemic lupus erythematosus (SLE) t…
…Objectives Hydroxychloroquine (HCQ) is recommended for the management of systemic lupus eryth…
…ental health support, inter-speciality fragmented care, and low lupus awareness among non-specialists. The findings provided a clear …
…frolumab treatmentConclusions In this real-world Danish cohort, anifrolumab produced substantial and sustained reductions in disease activi…